APPLICATION
ANDA208953
TYPE
ANDA
ORIGINAL APPROVAL
2020-02-12
LATEST ACTION
2024-03-28
ROUTE
RECTAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Prescription
Products
MESALAMINEPrescription
MESALAMINE 1GM · SUPPOSITORY · RECTAL
Approval history
2024-03-28Labeling · Supplement 7 · standardAP
2023-11-27Labeling · Supplement 6 · standardAP
2022-10-28Labeling · Supplement 5 · standardAP
2022-10-28Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.